Positron Emission Tomography for the Staging of Hodgkin's Lymphoma - Increasing the Body of Evidence in Favor of the Method

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Acta oncologica

• Publication date

  2002-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/028418602320405014PMID 12442918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.

  2002cited by this paper
• A systematic overview of chemotherapy effects in Hodgkin's disease.

  2001cited by this paper
• FDG-PET for clinical use

  2001cited by this paper
• FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.

  2001cited by this paper
• Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease

  2001cited by this paper
• 2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution.

  2000cited by this paper
• Positron emission tomography for detection and staging of malignant lymphoma.

  2000cited by this paper
• Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease.

  1999cited by this paper
• Detection of lymphoma in bone marrow by whole-body positron emission tomography.

  1998cited by this paper
• 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.

  1998cited by this paper
• Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma.

  1997cited by this paper
• Diagnostic accuracy of ultrasound and computed tomography in the staging of Hodgkin's disease. Verification by laparotomy in 100 cases

  1995cited by this paper

• Functional Imaging in Hodgkin Lymphoma

  2020cites this paper
• PET/CT for Staging; Past, Present, and Future.

  2018cites this paper
• Advancing Precision Nuclear Medicine and Molecular Imaging for Lymphoma.

  2017cites this paper
• The prognostic value of positron emission tomography performed after two courses (INTERIM‐PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL)

  2015cites this paper
• Performance of FDG PET/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma

  2014cites this paper
• HODGKINOV LIMFOM: POVEZANOST NALAZA POZITRONSKE EMISIJSKE TOMOGRAFIJE NAKON DVA CIKLUSA KEMOTERAPIJE NA KONAČNI ISHOD LIJEČENJA

  2014cites this paper
• PET/CT: appropriate application in lymphoma.

  2014cites this paper
• Positron emission tomographic scans in lymphoma: convention and controversy.

  2012cites this paper
• Stellenwert der PET/CT in der Lymphomdiagnostik

  2012cites this paper
• Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions.

  2011cites this paper
• FDG PET/CT in Evaluation of Pyrexia of Unknown Origin

  2011cites this paper
• [Non-Hodgkin's lymphoma staging with PET-CT scan].

  2011cites this paper
• Estadificación de los linfomas no hodgkinianos con PET-TC

  2011cites this paper
• TEP/TDM dans le diagnostic et la stadification des lymphomes

  2011cites this paper
• Impact of FDG-PET/CT in the management of lymphoma

  2011cites this paper
• FDG-PET/CT in lymphoma.

  2011cites this paper
• PET-CT Imaging of Lymphoma

  2010cites this paper
• Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma.

  2009cites this paper
• Positron Emission Tomography With 2-[18F]-Fluoro-2-Deoxy-D-Glucose For Initial Staging Of Hodgkin Lymphoma: A Single Center Experience In Brazil

  2009influential citation
• Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma

  2009cites this paper
• PET imaging in lymphoma

  2009cites this paper
• New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.

  2008cites this paper
• New response criteria for lymphomas in clinical trials.

  2008cites this paper
• 18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin’s disease

  2008cites this paper
• Staging and evaluation of the patient with lymphoma.

  2008cites this paper
• PET/CT in the management of haematological malignancies

  2008cites this paper
• The role of FDG-PET scans in patients with lymphoma.

  2007cites this paper
• Early ResponseAssessment Using 3 ¶-Deoxy-3 ¶-[ 18 F ] Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin ’ s Lymphoma

  2007cites this paper
• Clinical impact of FDG‐PET/CT in the planning of radiotherapy for early‐stage Hodgkin lymphoma

  2007cites this paper
• FDG-PET scan and treatment planning for early stage Hodgkin lymphoma.

  2007cites this paper
• Early Response Assessment Using 3′-Deoxy-3′-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma

  2007cites this paper
• The role of FDG PET in the management of lymphoma: what is the evidence base?

  2007cites this paper
• 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.

  2007cites this paper
• Hodgkin’s Disease and Lymphomas

  2007cites this paper
• Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?

  2006cites this paper
• Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.

  2006cites this paper
• Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake

  2006cites this paper
• Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease.

  2006cites this paper
• Chapter 11 – Nuclear Medicine

  2006cites this paper
• PET and PET/CT Imaging in Lymphoma

  2006cites this paper
• Capítulo siete – Neoplasias pulmonares

  2006cites this paper
• Utility of positron emission tomography (PET) scanning in managing patients with Hodgkin lymphoma.

  2006cites this paper
• Utility of FDG-PET/CT in Follow-Up of Children Treated for Hodgkin and Non-Hodgkin Lymphoma

  2006cites this paper
• Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin’s disease

  2006cites this paper
• 18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results.

  2005cites this paper
• A metaanalysis of 18F‐2‐deoxy‐2‐fluoro‐D‐glucose positron emission tomography in the staging and restaging of patients with lymphoma

  2005cites this paper
• Clinical Condition: Staging Evaluation—Hodgkin's Lymphoma Variant 1: Child with biopsy-proven clinical stage (CS) IIA NSHD presenting with neck nodes and mediastinal disease on chest radiograph.

  2005cites this paper
• Nodal Involvement in Hodgkin Disease

  2004cites this paper
• FDG-PET in the clinical management of Hodgkin lymphoma.

  2004influential citation
• Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma

  2004cites this paper
• Atypical thoracic and supraclavicular FDG-uptake in patients with Hodgkin's and non-Hodgkin's lymphoma.

  2004cites this paper
• Pretherapy Gallium-67 Scanning in Paediatric Patients with Hodgkin’s Disease

  2004cites this paper
• Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas.

  2004cites this paper
• Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease.

  2004cites this paper
• Positron Emission Tomography in Patients with Hodgkin's Disease: Correlation to Histopathologic Subtypes

  2003cites this paper
• Lymphoma : Burkitt lymphoma 401

  2003cites this paper
• PET imaging of Rosai-Dorfman disease: correlation with histopathology and ex-vivo beta-imaging

  2003cites this paper
• 18F-Deoxyglucose PET for the staging of oesophageal cancer

  2003cites this paper
• Functional imaging

  2001cites this paper